Literature DB >> 33864807

Fluid volume regulation in patients with heart failure.

Atsushi Tanaka1, Koichi Node2.   

Abstract

Entities:  

Year:  2021        PMID： 33864807     DOI： 10.1016/S2213-8587(21)00082-6

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  2 in total

1.  Body fluid regulation via chronic inhibition of sodium-glucose cotransporter-2 in patients with heart failure: a post hoc analysis of the CANDLE trial.

Authors:  Shinya Fujiki; Atsushi Tanaka; Takumi Imai; Michio Shimabukuro; Hiroki Uehara; Ikuko Nakamura; Kazuo Matsunaga; Makoto Suzuki; Takeshi Kashimura; Tohru Minamino; Takayuki Inomata; Koichi Node
Journal:  Clin Res Cardiol       Date:  2022-06-22       Impact factor: 5.460

2.  Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized EMBLEM trial.

Authors:  Atsushi Tanaka; Michio Shimabukuro; Hiroki Teragawa; Yosuke Okada; Toshinari Takamura; Isao Taguchi; Shigeru Toyoda; Hirofumi Tomiyama; Shinichiro Ueda; Yukihito Higashi; Koichi Node
Journal:  Cardiovasc Diabetol       Date:  2021-06-28       Impact factor: 9.951
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.